Turn Therapeutics (TTRX) Enterprise Value (2024 - 2026)

Turn Therapeutics has reported Enterprise Value for 3 years, with the latest figure at -$11.0 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value changed N/A year-over-year to -$11.0 million; the trailing twelve-month figure through Mar 2026 stood at -$11.0 million (changed N/A YoY), and the FY2025 full-year result was -$4.0 million, down 708.34% from the prior year.
• Enterprise Value for Q1 2026 stood at -$11.0 million, down from -$4.0 million in the prior quarter.
• The five-year high for Enterprise Value was -$498286.0 in Q3 2024, with the low at -$11.0 million in Q1 2026.
• Average Enterprise Value over 3 years is -$3.3 million, with a median of -$513695.0 recorded in 2025.
• Peak annual rise in Enterprise Value reached 3.09% in 2025, while the deepest fall reached 708.34% in 2025.
• Tracing TTRX's Enterprise Value over 3 years: stood at -$498286.0 in 2024, then slumped by 708.34% to -$4.0 million in 2025, then slumped by 173.33% to -$11.0 million in 2026.
• The last three Enterprise Value figures came in at -$11.0 million (Q1 2026), -$4.0 million (Q4 2025), and -$513695.0 (Q3 2025), per Business Quant data.

Peer Comparison